Dharti Proteins Q2 Results and Bonus Share Update

Q2 FY27 Net Profit: Rs 3.37 crore
1:1 Bonus Issue: Restricted to public shareholders

Reader Takeaway: Turnaround driven by one-time loan waiver; bonus issue aims to meet regulatory public holding requirements.

What just happened

Dharti Proteins reported a net profit of Rs 3.37 crore for the quarter ending September 30, 2026, compared to a net loss of Rs 14.28 lakh in the previous quarter. Revenue from operations stood at Rs 285.13 lakh. The company also announced an extraordinary general meeting (EGM) scheduled for November 6, 2026, to seek shareholder approval for a 1:1 bonus equity share issue specifically for public shareholders.

Why this matters

The reported profitability is significantly influenced by a one-time gain. The company recorded Rs 314.50 lakh as 'Other Income' following the waiver of an unsecured loan by the Managing Director. Excluding this non-recurring accounting item, the core operating performance remains a key focus for investors assessing long-term sustainability. The bonus issue is a strategic move to align with Rule 19A of the Securities Contracts (Regulation) Rules, 1957, regarding minimum public shareholding.

What changes now

Following the board's decision, the company is transitioning its Registrar and Transfer Agent (RTA) to Bigshare Services Private Limited. Additionally, the board has appointed M/S J M Patel & Bros as tax auditors for FY 2026-27.

Risks to watch

Investors should closely monitor the core operational margins, as the current quarter's profit is heavily tied to the debt waiver. Furthermore, the bonus issue is limited to public shareholders, and investors should wait for the formal disclosure of the record date and eligibility criteria.

What to track next

The outcome of the EGM on November 6, 2026, is critical for the implementation of the bonus issue. Shareholders should also watch for subsequent disclosures regarding the record date and the specific mechanics of the bonus share distribution.